Literature DB >> 1168988

Carcinoembryonic antigen in patients suffering from ulcerative proctocolitis.

A B Mitchell, A M Gill, R T Orchard, R A Parkins.   

Abstract

Carcinoembryonic antigen (CEA) has been measured by radioimmunoassay in samples obtained from all patients suffering from ulcerative proctocolitis and seen within a four-month period. The characteristics of this group of patients have been compared with reported epidemiological studies in this disease, and have been found to have a similar sex ratio and age of onset, but a more limited disease. Among 59 patients, 11 were found to have elevated circulating CEA values. One of the 11 had a colonic carcinoma and another was pregnant. Excluding these two patients, an overall prevalence of elevated CEA levels of 17.5% was found. The prevelance in ulcerative proctitis was 7.1%, and in colitis was 19.9%. The patients in whom elelvated plasma CEA values were found were compared with the remaining patients in relation to factors known to be associated with an increased propensity for the development of colorectal carcinoma complicating ulcerative colitis. There was no difference in mean age of the patients at disease onset, nor was there any difference in disease duration, extent, and control. A significant correlation was found between elevated plasma CEA levels and the severity of the initial attack. One patient with premalignant changes in the rectal mucosa had consistently normal concentrations of plasma CEA. There was no significant correlation between elevated plasma CEA values and disease activity. The mean age of the two groups of patients was similar. No carcinoma has manifested in any patient during follow-up periods of at least 18 months.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1168988     DOI: 10.1007/bf01070784

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  55 in total

1.  Life histories of patients with chronic ulcerative colitis: a review of 2,000 cases.

Authors:  W P SLOAN; J A BARGEN; R P GAGE
Journal:  Gastroenterology       Date:  1950-09       Impact factor: 22.682

2.  Cellular and humoral immunity to different types of human neoplasms.

Authors:  I Hellström; K E Hellström; G E Pierce; J P Yang
Journal:  Nature       Date:  1968-12-28       Impact factor: 49.962

3.  Tumor-associated antigen in patients with carcinoma of the colon.

Authors:  P Lo Gerfo; F Lo Gerfo; F Herter; H G Barker; H J Hansen
Journal:  Am J Surg       Date:  1972-02       Impact factor: 2.565

4.  Intestinal malignancy and Crohn's disease.

Authors:  P F Schofield
Journal:  Proc R Soc Med       Date:  1972-09

5.  Radioimmune assay of carcinoembryonic antigen.

Authors:  M L Egan; J T Lautenschleger; J E Coligan; C W Todd
Journal:  Immunochemistry       Date:  1972-03

6.  Absence of circulating antibodies to carcinoembryonic antigen in patients with gastrointestinal malignancies.

Authors:  P Lo Gerfo; F P Herter; S J Bennett
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396

7.  Carcinoembryonic antigen assay in cancer of the colon and pancreas and other digestive tract disorders.

Authors:  T L Moore; H Z Kupchik; N Marcon; N Zamcheck
Journal:  Am J Dig Dis       Date:  1971-01

8.  Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum.

Authors:  F T De Dombal; J M Watts; G Watkinson; J C Goligher
Journal:  Br Med J       Date:  1966-06-11

9.  A collaborative study of a test for carcinoembryonic antigen (CEA) in the sera of patients with carcinoma of the colon and rectum. A joint National Cancer Institute of Canada-American Cancer Society investigation.

Authors: 
Journal:  Can Med Assoc J       Date:  1972-07-08       Impact factor: 8.262

10.  Specificity of the carcinoembryonic antigen (CEA).

Authors:  J J Collins; P H Black
Journal:  N Engl J Med       Date:  1971-07-15       Impact factor: 91.245

View more
  1 in total

1.  Serial carcinoembryonic antigen (CEA) blood levels in patients with ulcerative colitis.

Authors:  R C Gardner; A E Feinerman; P A Kantrowitz; S Gottblatt; M S Loewenstein; N Zamcheck
Journal:  Am J Dig Dis       Date:  1978-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.